X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
index medicus (15) 15
oncology (11) 11
cancer (10) 10
chemotherapy (9) 9
female (9) 9
middle aged (9) 9
male (7) 7
radiotherapy (7) 7
radiation-therapy (6) 6
toxicity (6) 6
treatment outcome (6) 6
adult (5) 5
aged (5) 5
radiation therapy (5) 5
retrospective studies (5) 5
trial (5) 5
care and treatment (4) 4
chemoradiotherapy - adverse effects (4) 4
efficacy (4) 4
prognosis (4) 4
targeted therapies (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
antineoplastic agents - adverse effects (3) 3
cell biology (3) 3
chemoradiotherapy - methods (3) 3
hematology, oncology and palliative medicine (3) 3
history, 21st century (3) 3
immunotherapy (3) 3
metastasis (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
radiology, nuclear medicine & medical imaging (3) 3
radiotherapy - methods (3) 3
safety (3) 3
survival analysis (3) 3
therapy (3) 3
[ phys.phys.phys-med-ph ] physics [physics]/physics [physics]/medical physics [physics.med-ph] (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
agents (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bevacizumab (2) 2
breast cancer (2) 2
breast neoplasms - radiotherapy (2) 2
breast-cancer (2) 2
carcinoma (2) 2
chemoradiation (2) 2
cisplatin (2) 2
combination (2) 2
concomitant radiochemotherapy (2) 2
concurrent (2) 2
development and progression (2) 2
guideline adherence (2) 2
history, 20th century (2) 2
impact (2) 2
innovations (2) 2
intensity-modulated radiotherapy (2) 2
irradiation (2) 2
life sciences (2) 2
lung cancer, non-small cell (2) 2
management (2) 2
medical physics (2) 2
medical physics. medical radiology. nuclear medicine (2) 2
melanoma (2) 2
molecular targeted therapy (2) 2
neoplasms - mortality (2) 2
neoplasms - pathology (2) 2
neoplasms - radiotherapy (2) 2
neoplasms - therapy (2) 2
organs at risk - radiation effects (2) 2
patients (2) 2
pharmacology & pharmacy (2) 2
phase-iii (2) 2
physics (2) 2
pilot projects (2) 2
prospective studies (2) 2
prostatic neoplasms - radiotherapy (2) 2
radiation (2) 2
radiometry (2) 2
radiotherapy - adverse effects (2) 2
radiotherapy dosage (2) 2
radiotherapy, intensity-modulated - methods (2) 2
renal cell carcinoma (2) 2
resistance (2) 2
review (2) 2
short communication (2) 2
squamous cell carcinoma (2) 2
squamous-cell carcinoma (2) 2
stem (2) 2
sunitinib (2) 2
surgery (2) 2
surveys and questionnaires (2) 2
survival (2) 2
tolerance (2) 2
tomography, x-ray computed (2) 2
women (2) 2
young adult (2) 2
[ sdv ] life sciences [q-bio] (1) 1
adaptation, psychological (1) 1
administration, intravenous (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Head & Neck, ISSN 1043-3074, 07/2016, Volume 38, Issue 7, pp. 1028 - 1034
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 06/2016, Volume 27, Issue 5, pp. 427 - 432
Journal Article
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 02/2017, Volume 104, Issue 2, pp. 167 - 176
We have just celebrated the 50th anniversary of cisplatin cytotoxic potential discovery. It is time to take stock… and it seems mainly positive. This drug,... 
Resistance | Chemotherapy | Oxaliplatin | Carboplatin | Toxicities | Cisplatin
Journal Article
Journal Article
Radiation oncology (London, England), ISSN 1748-717X, 03/2018, Volume 13, Issue 1, pp. 50 - 1
In the original publication [1] one author name was spelled incorrect. 
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 2015, Volume 102, Issue 10, pp. 814 - 822
Introduction: Trabectedin proved its efficacy in relapsed advanced soft tissue sarcomas (STS) in 3 multicenter phase II studies with selected patients. The aim... 
Soft tissue sarcoma | Tolerance | Efficacy | Relapse | Trabectedin | STANDARD-DOSE DOXORUBICIN | SINGLE INSTITUTION | PHASE-II | IFOSFAMIDE | CHEMOTHERAPY | TRIAL | ONCOLOGY | ECTEINASCIDIN-743 | EUROPEAN-ORGANIZATION | BONE
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 46, pp. 81485 - 81491
Background: Cancer patients tend to use more and more complementary or alternative medicine concomitantly to radiotherapy. A large part of these patients have... 
Supportive care | Complementary and alternative medicine (CAM) | Breast cancer | Radiation therapy | Prostate cancer | BREAST-CANCER | TRIALS | prostate cancer | supportive care | FATIGUE | complementary and alternative medicine (CAM) | radiation therapy | ALTERNATIVE MEDICINE USE | breast cancer | COMPLEMENTARY MEDICINE | CELL BIOLOGY
Journal Article